Related Experiment Video
Updated: Oct 29, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.0K
Recent advances in developing small-molecule inhibitors against SARS-CoV-2.
Rong Xiang1, Zhengsen Yu1, Yang Wang1
1College of Life Sciences, Hebei Agricultural University, Baoding 071001, China.
Acta Pharmaceutica Sinica. B
|July 12, 2021
Summary
Researchers are identifying therapeutic targets within the SARS-CoV-2 life cycle to develop new treatments for COVID-19. This work aims to create effective small-molecule drugs for preventing and treating infections caused by the novel coronavirus.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, necessitates advanced treatment strategies beyond current vaccines.
- Understanding viral pathogenesis and mutant strains is crucial for identifying effective therapeutic targets.
Purpose of the Study:
- To summarize potential therapeutic targets in the SARS-CoV-2 life cycle.
- To inform the development of novel prophylactic and therapeutic agents against SARS-CoV-2.
Main Methods:
- Literature review of SARS-CoV-2 genome structure, epidemiology, and pathogenesis.
- Identification of key viral targets based on current scientific understanding.
Main Results:
- Detailed understanding of SARS-CoV-2's genome, clinical features, and pathogenic mechanisms.
- Identification of specific targets within the viral life cycle.
Conclusions:
- Therapeutic targets within the SARS-CoV-2 life cycle are being actively investigated.
- Small-molecule agents are under development for the prevention and treatment of COVID-19.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
17.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.4K
01:28Structure-Activity Relationships and Drug Design
1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K